Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Vaccizone logo — Exploring advanced techniques for antigen delivery in modern...

Vaccizone

Exploring advanced techniques for antigen delivery in modern medicine.

Founded 2019 Turkey Turkey 4 employees Angel Biotechnology, Manufacturing +1

General Information

Company Name Vaccizone
Founded Year 2019
Location Turkey Turkey
Employees 4
Industries Biotechnology, Manufacturing, Pharmaceutical
Funding Stage Angel
Social

BounceWatch is an independent company data service, not affiliated with Vaccizone. To contact Vaccizone, visit vaccizone.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vaccizone compare?

A PDF of Vaccizone and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vaccizone soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vaccizone

Vaccizone is a biotechnology startup that focuses on exploring advanced techniques for antigen delivery in modern medicine. The company's slogan emphasizes its commitment to developing innovative approaches to enhance the immune system's response against cancer, with the aim of improving treatment efficacy and patient outcomes. Since its establishment in 2019, Vaccizone has been working on technologies for precise antigen delivery, which hold significant promise in the fight against cancer.

Based in Turkey, Vaccizone operates within the Biotechnology, Manufacturing, and Pharmaceutical industries. The startup recently received an Angel Round investment on 28 May 2021, with Keiretsu Forum Turkey being the participating investors. This injection of funding is expected to further support the company's research and development efforts, as well as its overall growth trajectory within the biotech sector.

Business keywords: Antigen Delivery, Cancer Immunotherapy, Vaccine Technologies, ASC Technology, Treatment Development, Immunotherapy, Disease Prevention, Innovative Therapies

Services & Products

Next generation antigen delivery and vaccine technologies for human and animal diseases

Target Customers

Pharmaceutical companies research institutions veterinary clinics healthcare organizations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round Undisclosed 1
Keiretsu Forum Turkey
Keiretsu Forum Turkey
28 May 2021

Vaccizone Alternatives & Competitors

View All Alternatives
Vaccizone vs
Memgen, Inc.
Memgen, Inc. United States

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

Venture round
7 employees
Biotechnology, Health Care
Vaccizone vs
BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. United States

Developing Novel Therapies to Destroy Cancer

Post-IPO Equity
20 employees
Biotechnology, Health Care
Vaccizone vs
Prokarium
Prokarium United Kingdom

LIVING CURES

16 employees
Biotechnology, Health Care
View all alternatives

FAQ About Vaccizone

Exploring advanced techniques for antigen delivery in modern medicine.
Vaccizone was founded in 2019.
Vaccizone is headquartered in Turkey.
Vaccizone operates in Biotechnology, Manufacturing and Pharmaceutical. Its work centres on Antigen Delivery, Cancer Immunotherapy, Vaccine Technologies and ASC Technology. Its customers include Pharmaceutical companies, research institutions and veterinary clinics.
Vaccizone has approximately 4 employees.
Vaccizone has completed 1 funding round. The latest funding stage is Angel.
Vaccizone offers: Next generation antigen delivery and vaccine technologies for human and animal diseases.
Top alternatives and competitors to Vaccizone include Memgen, Inc., BriaCell Therapeutics Corp., Prokarium, Veana Therapeutics, Inc., Brenus Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vaccizone and Memgen, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vaccizone, https://bouncewatch.com/company/vaccizone, updated 24 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout